Related Experiment Video

Updated: Jul 6, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Malignant mesothelioma resistance to apoptosis: recent discoveries and their implication for effective therapeutic

F Villanova1, A Procopio, M R Rippo

  • 1Laboratory of Experimental Pathology, Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Ancona, Italy.

Current Medicinal Chemistry
|March 14, 2008
PubMed

Insights

Malignant mesothelioma, a fatal cancer linked to asbestos, is increasing globally. Understanding its resistance to apoptosis is key to developing new therapies and improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Environmental Health

Background:

  • Malignant mesothelioma is an aggressive, fatal cancer with increasing incidence worldwide, particularly in Europe and Australia.
  • Asbestos exposure is the primary risk factor, though co-factors like simian virus 40 (SV40) may play a role.
  • Rising incidence is projected, especially in industrializing nations and following events like the World Trade Center Disaster.

Purpose of the Study:

  • To review the anti-apoptotic strategies employed by malignant mesothelioma.
  • To explore therapeutic implications and opportunities arising from understanding these mechanisms.

Main Methods:

  • Literature review of molecular mechanisms of mesothelioma.
  • Analysis of anti-apoptotic pathways in malignant mesothelioma.
  • Synthesis of current and future therapeutic strategies.

Main Results:

  • Malignant mesothelioma exhibits resistance to apoptosis, a key factor in its treatment resistance.
  • Understanding molecular mechanisms of apoptosis evasion is advancing.
  • New therapeutic strategies are emerging based on these insights.

Conclusions:

  • Targeting anti-apoptotic mechanisms offers promising therapeutic avenues for malignant mesothelioma.
  • Improved understanding of molecular resistance can change the natural history and survival of patients.
  • Further research is crucial for developing effective treatments against this aggressive cancer.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...